LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA. Abramovic I, Pezelj I, Dumbovic L, Skara Abramovic L, et al. Prostate 2024 Jun 2. doi: 10.1002/pros.24749.

Read + Share

Amedeo Smart

Independent Medical Education

Abramovic I, Pezelj I, Dumbovic L, Skara Abramovic L, et al. LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA. Prostate 2024 Jun 2. doi: 10.1002/pros.24749.
PMID: 38824441